AMN Healthcare Services (AMN) FY2018 results: revenue $2.1 billion, up 7.4% on the year
AMN Healthcare Services Inc. (AMN) reported revenue of $2.1 billion for fiscal 2018, the year ended 31 December 2018, up 7.4% on the year before. Net income was $142 million, up 6.9%, and diluted earnings per share $2.91. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2019.
Revenue
$2.1 billion
+7.4% on the year
FY2011FY2018
Operating margin
9.5%
10.7% a year earlier
FY2011FY2018
Net income
$142 million
+6.9% on the year
FY2011FY2018
Diluted EPS
$2.91
+8.6% on the year
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
2,136
1,988
1,902
+7.4%
Cost of revenue
1,440
1,344
1,283
+7.1%
Gross profit
696
644
620
+8.1%
Gross margin
32.6%
32.4%
32.6%
Selling, general and administrative
452
400
398
+13.2%
Operating income
203
212
192
-4.5%
Operating margin
9.5%
10.7%
10.1%
Interest expense
16.1
19.7
15.5
-18.0%
Pre-tax income
187
193
176
-3.2%
Income tax
44.9
60.2
70.3
-25.3%
Effective tax rate
24.1%
31.2%
39.9%
Net income
142
133
106
+6.9%
Net margin
6.6%
6.7%
5.6%
Diluted EPS
$2.91
$2.68
$2.15
+8.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
227
161
134
+41.4%
Capital expenditure
35.2
26.5
22.0
+32.7%
Free cash flow
192
134
112
+43.1%
Free cash flow margin
9.0%
6.7%
5.9%
Cash from investing
-279
-35.4
-258
Cash from financing
37.5
-77.2
126
Depreciation and amortisation
41.2
32.3
29.6
+27.8%
Share-based compensation
10.8
10.2
11.4
+5.6%
Buybacks
67.0
20.2
13.3
+232.3%
Diluted shares, weighted
49m
49m
49m
-1.5%
Shares outstanding at period end
47m
47m
48m
-1.8%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
639
563
449
+13.6%
Debt
441
320
363
+37.8%
Other liabilities
413
372
375
+11.2%
Total liabilities and equity
1,493
1,254
1,187
+19.0%
Fixed assets
90.4
73.4
60.0
+23.1%
Goodwill
439
341
342
+28.7%
Intangible assets
326
227
246
+43.6%
Cash and equivalents
13.9
15.1
10.6
-8.5%
Receivables
366
350
342
+4.4%
Other assets
258
247
187
+4.3%
Total assets
1,493
1,254
1,187
+19.0%
10-K for the year ended 31 December 2018, filed 21 February 2019: the filing.